Results 111 to 120 of about 404,128 (166)

Left Ventricular Hypertrophy With Strain and Aortic Stenosis

open access: yesCirculation, 2014
Anoop S. V. Shah   +14 more
semanticscholar   +1 more source

Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension.

open access: yesJournal of the American College of Cardiology, 1992
A. Ganau   +8 more
semanticscholar   +1 more source

Left ventricular hypertrophy: diagnostics pitfalls

open access: yesSwiss Medical Weekly, 2004
Swiss Medical Weekly
doaj   +1 more source

Long-Term Control of Arterial Hypertension and Regression of Left Ventricular Hypertrophy With Treatment of Primary Aldosteronism

open access: yesHYPERTENSION, 2013
G. Rossi   +7 more
semanticscholar   +1 more source

Effect of Combined Systolic and Diastolic Functional Parameter Assessment for Differentiation of Cardiac Amyloidosis From Other Causes of Concentric Left Ventricular Hypertrophy

open access: yesCirculation Cardiovascular Imaging, 2013
Dan Liu   +10 more
semanticscholar   +1 more source

159 ALLOPURINOL REDUCES LEFT VENTRICULAR MASS IN PATIENTS WITH TYPE 2 DIABETES AND LEFT VENTRICULAR HYPERTROPHY

open access: yesHeart, 2013
B. Szwejkowski   +7 more
semanticscholar   +1 more source

Blood Pressure and Left Ventricular Hypertrophy During American-Style Football Participation

open access: yesCirculation, 2013
R. Weiner   +9 more
semanticscholar   +1 more source

Prevalence of left-ventricular hypertrophy in hypertension: an updated review of echocardiographic studies

open access: yesJournal of Human Hypertension, 2012
C. Cuspidi   +5 more
semanticscholar   +1 more source

Fibroblast Growth Factor 23 and Left Ventricular Hypertrophy in Chronic Kidney Disease

open access: yesCirculation, 2009
O. Gutiérrez   +12 more
semanticscholar   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Left ventricular hypertrophy and hypertension.

Progress in Cardiovascular Diseases, 2019
Hypertension (HTN) is a major modifiable risk factor for cardiovascular disease (CVD) morbidity and mortality. The left ventricle (LV) is a primary target for HTN end-organ damage. In addition to being a marker of HTN, LV geometrical changes: concentric remodeling, concentric or eccentric LV hypertrophy (LVH) are major independent risk factors for not ...
M. Yildiz   +5 more
semanticscholar   +4 more sources

Home - About - Disclaimer - Privacy